Minimize

NOTE: NRG Oncology studies have been moved to the NRG Oncology website protocol table. Only terminated studies remain on this list. 

Disease Sites Table

Minimize

RTOG Clinical Trials Listed by Study Number

Filter the listings by choosing the options in the drop down boxes and then click on the desired protocol number.
Disease Category:   Site:
Protocol Status:   Phase:
Study Name Status Phase
0011 Phase III Randomized Study of Adjuvant Therapy for High Risk pT2-3N0 Prostate Cancer Terminated III
0012 Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation for Distal Rectal Cancer Terminated II
0013 A Phase II Trial of Conventional Radiation Therapy followed by Intratumoral Bleomycin Delivered using a Refillable Sustained Device (IND#46,592) for the Treatment of Supratentorial Glioblastoma Terminated II
0014 A Phase III Randomized Study of Patients with High Risk, Hormone-Naive Prostate Cancer: Androgen Blockade with 4 Cycles of Immediate Chemotherapy versus Androgen Blockade with Delayed Chemotherapy Terminated III
0015 SWOG 9900/Endorsed Study: A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC) Terminated III
0017 A Phase I Study of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Radiation Therapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Terminated I
0018 A Feasibility Study of Neurocognitive Evaluation in Patients Treated for Brain Metastases Terminated I
0019 A Phase II Study of External Beam Radiation Therapy Combined with Permanent Source Brachytherapy for Intermediate Risk Clinically Localized Adenocarcinoma of the Prostate Terminated II
0020 A Randomized Phase II Trial of Weekly Gemcitabine, Paclitaxel and External Irradiation (50.4 Gy) Followed by the Farnesyl Transferase Inhibitor R115777 (NSC #702818) for Locally Advanced Pancreatic Cancer Terminated II
0021 A Phase II Trial of Conventional Radiation Therapy plus High Dose Tamoxifen for the Treatment of Supratentorial Glioblastoma Multiforme (GBM) Terminated II
0022 Phase I/II Study of Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer Terminated I/II
0023 A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts for Supratentorial Glioblastoma Multiforme Terminated II
0024 Phase II Trial of Early Postoperative Paclitaxel Followed By Paclitaxel and Cisplatin Concurrent With Radiation Therapy for Resected, High-Risk Squamous Carcinoma of the Head and Neck Terminated II
0113 Non-operative Therapy of Local Regional Carcinoma of the Esophagus: A Randomized Phase II Study of Two Paclitaxel-Based Chemoradiotherapy Regimens Terminated II
0114 Randomized Phase II Comparison of Two Cisplatin-Paclitaxel Containing Chemoradiation Regimens in Resected Gastric Cancers Terminated II
0116 A Two Part Phase I/II Study of Extended Field External Irradiation and Intracavitary Brachytherapy Combined with Chemotherapy and Amifostine in Carcinoma of the Cervix with Positive Para-Aortic or High Common Iliac Lymph Nodes Terminated I/II
0117 A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients with Inoperable, Non-Small Cell Lung Cancer Terminated I/II
0118 A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (Nsc# 66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases Terminated III
0119 A Randomized Phase II Study of A.M. And P.M. Melatonin for Brain Metastasis in RPA Class II Patients Terminated II
0120 A Randomized Phase I/II Study of Preoperative Radiotherapy With/Without Sugen 5416 (NSC #696819; A TK Inhibitor Anti-Angiogenesis Compound) in the Management of Low to Intermediate Grade Soft Tissue Sarcoma of the Trunk or Extremity Terminated I/II
0121 A Phase I/II Study of Neoadjuvant Chemotherapy, Angiogenesis Inhibitor SU5416 (NSC #696819; A TK Inhibitor Anti-Angiogenesis Compound), and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall Terminated I/II
0122 A Double-Blind Study of Nutritional Intervention for the Treatment of Cancer Cachexia Using Juven® Nutritional Supplement Terminated I
0123 A Phase II Randomized Trial With Captopril in Patients Who Have Received Radiation Therapy +/ Chemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer or Limited Stage Small Cell Lung Cancer---RTOG CCOP Study Terminated II
0124 A Phase II Study of Multimodality Therapy for Primary and Recurrent Retroperitoneal Sarcomas Terminated II
0128 A Phase I/II Study of Cox-2 Inhibitor, Celebrex™ (Celecoxib) And Chemo-Radiation In Patients With Locally Advanced Cervical Cancer Terminated I/II
0132 A Phase II Trial of Neoadjuvant/Adjuvant STI-571 (Gleevec NSC #716051) for Primary and Recurrent Operable Malignant GIST Expressing the Kit Receptor Tyrosine Kinase (CD117) Terminated II
0211 A Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor (EGFR-TKI), ZD 1839 (IRESSA) [NSC# 715055] with Radiation Therapy in Glioblastoma Multiforme Terminated I/II
0212 A Phase II/III Randomized Trial of Two Dose Schedules for Delivering Prophylactic Cranial Irradiation for Patients with Limited Disease Small Cell Lung Cancer (Companion Study to the International Cranial Irradiation Trial, PCI 01EULINT1) Terminated II/III
0213 A Phase I/II Trial of a Cox2 Inhibitor, Celebrex™ (Celecoib), [NSC# 719627] with Limited Field Radiation for Intermediate Prognosis Patients with Locally Advanced Non-Small Cell Lung Cancer, with Analysis of Prognostic Factors Terminated I/II
0214 A Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer Terminated III
0215 Treatment of Erectile Dysfunction in Patients Treated on RTOG 9910 for Prostate Cancer: Impact on Patient and Partner Quality of Life---RTOG CCOP Study Terminated III
0225 A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) +/ Chemotherapy for Nasopharyngeal Cancer Terminated II
0227 Phase I/II Study of Pre-Irradiation Chemotherapy with Methotrexate, Rituximab, and Temozolomide and Post-Irradiation Temozolomide for Primary Central Nervous System Lymphoma Terminated I/II
0229 A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and High Dose Radiotherapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-Small Cell Lung Carcinoma Terminated II
0234 A Phase II Randomized Trial of Surgery Followed by Chemoradiotherapy Plus C225 (Cetuximab) for Advanced Squamous Cell Carcinoma of the Head and Neck Terminated II
0235 ACRIN 6668: Positron Emission Tomography Pre- and Post-Treatment Assessment for Locally Advanced Non-Small Cell Lung Carcinoma Terminated I
0236 A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer Terminated II
0239 A Phase II Study of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer Terminated II
0241 Phase I Study of Irinotecan and Cisplatin in Combination With Twice Daily Thoracic Radiotherapy (45 Gy) or Once Daily Thoracic Radiotherapy (70 Gy) For Patients With Limited Stage Small Cell Lung Cancer Terminated I
0244 A Phase II Study of Submandibular Salivary Gland Transfer to the Submental Space Prior to Start of Radiation Treatment for Prevention of Radiation-Induced Xerostomia in Head and Neck Cancer Patients Terminated II
0246 A Phase II Study of a Paclitaxel-Based Chemoradiotherapy Regimen with Selective Surgical Salvage for Resectable Loco-Regionally Advanced Carcinoma of the Esophagus Terminated II
0247 Randomized Phase II Trial of Neoadjuvant Combined Modality Therapy for Locally Advanced Rectal Cancer Terminated II
0275 NCIC CTG BR.19/Endorsed Study:"A Phase III Prospective Randomized, Double-Blind, Placebo-Controlled Trial of the Epidermal Growth Factor Receptor Anatagonist ZD 1839 (IRESSA) in Completely Resected Stage IB, II, and IIIA Non-Small Cell Lung Cancer" Terminated III
0315 A Randomized, Double Blind, Placebo-Controlled Phase III Study to Determine the Efficacy of Sandostatin LAR® Depot (Octreotide Acetate) in Preventing or Reducing the Severity of Chemoradiation-Induced Diarrhea in Patients With Anal or Rectal Cancer---RTOG CCOP Study Terminated III
0319 A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity For Stage I And II Breast Carcinoma Terminated I/II
0320 A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases Terminated III
0321 Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate Terminated II
0324 A Phase II Study of Cetuximab (C225) In Combination with Chemoradiation in Patients with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) Terminated II
0330 A Pilot Phase II Study of Preoperative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue Sarcoma or Preoperative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity or Body Wall Terminated II
0411 A Phase II Study of Bevacizumab with Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer Terminated II
0412 Phase III Randomized Trial of Preoperative Chemotherapy Versus Preoperative Concurrent Chemotherapy and Thoracic Radiotherapy Followed by Surgical Resection and Consolidation Chemotherapy in Favorable Prognosis Patients with Stage IIIa (N2) Non-Small Cell Terminated III
0417 A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma Terminated II
0418 A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis +/ Chemotherapy for Postoperative Patients with either Endometrial or Cervical Carcinoma Terminated II
0420 Phase II Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide Plus Irinotecan for Glioblastoma Multiforme Terminated II
0421 A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent ReIrradiation and Chemotherapy Versus Chemotherapy Alone Terminated III
0433 NCIC CTG SC.20: A Phase III International Randomized Trial of Single versus Multiple Fractions for Re-Irradiation of Painful Bone Metastases---CCOP Study Terminated III
0435 A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548) for the Reduction of Oral Mucositis in Patients with Locally Advanced Head and Neck Cancer Receiving Radiation Therapy with Con Terminated I
0438 Phase I Trial of Highly Conformal Radiation Therapy for Patients with Liver Metastases Terminated I
0514 Establishment of a Head and Neck Cancer Tissue/Specimen Repository Terminated CS
0515 A Comparative Study of Gross Tumor Volume Definition With or Without PET Fusion for Patients with Non-Small Cell Lung Carcinoma Terminated I
0517 A Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer---RTOG CCOP Study Terminated III
0518 A Phase III Randomized Trial to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High-Grade and/or Locally Advanced Prostate Cancer---RTOG CCOP Study Terminated III
0525 Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma Terminated III
0529 A Phase II Evaluation of Dose-Painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal Terminated II
0571 CALGB 80101/Endorsed Study: A Phase III Intergroup Trial of Adjuvant Chemoradiation after Resection of Gastric or Gastroesophageal Adenocarcinoma Terminated III
0572 SWOG S0424/Endorsed Study: “Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men" Terminated CS
0611 Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence Terminated CS
0612 Investigating Markers of Radiation Outcome in Patients with Intermediate-Risk Prostate Cancer Using DNA Microarray Analysis: An RTOG Pilot Study Terminated CS
0614 A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy---RTOG CCOP Study Terminated III
0619 A Randomized Phase II Trial of Chemoradiotherapy Versus Chemoradiotherapy and Vandetanib For High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck Terminated II
0622 A Phase II Trial of Samarium 153 Followed By Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation In High-Risk, Clinically Non-Metastatic Prostate Cancer after Radical Prostatectomy Terminated II
0623 A Phase II Trial of Combined Modality Therapy with Growth Factor Support for Patients with Limited Stage Small Cell Lung Cancer Terminated II
0625 A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma Terminated II
0671 NCCTG 0574/Endorsed Study: Phase III Randomized Trial of Whole Brain Radiation in Addition to Radiosurgery in Patients with One to Three Cerebral Metastases Terminated III
0674 CALGB 90202/Endorsed Study: "A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone" Terminated III
0822 A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination with Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer Terminated II
0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Terminated III
0831 A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer---RTOG CCOP Study Terminated III
0841 Efficiency of Screening for Depression in Cancer Patients Receiving Radiotherapy---RTOG CCOP Study Terminated I
0870 CALGB 140503/Endorsed Study: "A Phase III Randomized Trial Of Lobectomy Versus Sublobar Resection For Small (< 2 Cm) Peripheral Non-Small Cell Lung Cancer" Terminated III
0873 NCIC CTG PR.11/Endorsed Study: "A Phase III Study Of Active Surveillance Therapy Against Radical Treatment In Patients Diagnosed With Favourable Risk Prostate Cancer (START)" Terminated III
0921 A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) With Concurrent Cisplatin and Bevacizumab Followed By Carboplatin and Paclitaxel For Patients with Endometrial Cancer Terminated II
0925 Natural History of Postoperative Cognitive Function, Quality of Life, and Seizure Control in Patients With Supratentorial Low-Risk Grade II Glioma Terminated III
0929 A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma Terminated I/II
0933 A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases--RTOG CCOP Study Terminated II
0937 Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC) Terminated II
0971 SWOG S0809/Endorsed Study: "A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)" Terminated II
0972 CALGB 30605/Endorsed Study: "A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer" Terminated II
1012 Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer - RTOG CCOP Study (open to U.S. sites only) Terminated II R
1021 A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) Terminated III
1070 GOG-0249/Endorsed Study: "A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma" Terminated III
1102 A Phase I Study of Induction Ganitumab (IND #113278) and Gemcitabine, Followed by Ganitumab, Capecitabine, and 3D-Conformal Radiation Therapy (3D-CRT) With Subsequent Maintenance Therapy for Locally Advanced Pancreatic Cancer Terminated I
1201 A Phase II Randomized Trial of High Versus Standard Intensity Local or Systemic Therapy for Unresectable Pancreatic Cancer Terminated II R
1221 Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer Terminated II R
7102 Split Course Radiation Therapy of Cancer Terminated II/III
8531 Phase III Study of Zoladex Adjuvant to Radiotherapy in Unfavorable Prognosis Carcinoma of the Prostate Terminated III
8903 A PHASE III TRIAL TO STUDY THE ROLE OF NEOADJUVANT MCV* CHEMOTHERAPY COMBINED WITH TRANSURETHRAL SURGERY PLUS CISPLATIN WITH RADIATION THERAPY FOR SELECTIVE BLADDER PRESERVATION IN PATIENTS WITH MUSCLE-INVADING BLADDER CANCER * MCV: Methotrexate, Cisplatin, Vinblastine Terminated III
9003 A Phase III Randomized Study to Compare Twice Daily Hyperfractionation, Accelerated Hyperfractionation with a Split and Accelerated Fractionation with Concomitant Boost to Standard Fractionation Radiotherapy for Squamous Cell Carcinomas of the Head and Neck Terminated III
9111 Phase III Trial to Preserve the Larynx: Induction Chemotherapy and Radiation Therapy versus Concomitant Chemotherapy and Radiation Therapy versus Radiation Therapy Terminated III
9202 A Phase III Trial of the Use of Long Term Total Androgen Suppression Following Neoadjuvant Hormonal Cytoreduction and Radiotherapy In Locally Advanced Carcinoma of the Prostate Terminated III
9309 A Phase III Comparison between Concurrent Chemotherapy plus Radiotherapy, and Concurrent Chemotherapy plus Radiotherapy Followed by Surgical Resection for Stage IIIA (N2) Non-Small Cell Lung Cancer Terminated III
9406 A Phase I/II Dose Escalation Study Using Three Dimensional Conformal Radiation Therapy for Adenocarcinoma of the Prostate Terminated I/II
9410 A Three-Arm Phase III Study Of Concomitant versus Sequential Chemotherapy and Thoracic Radiotherapy for Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer Terminated III
9413 A Phase III Trial Comparing Whole Pelvic Irradiation Followed by a Conedown Boost to Boost Irradiation Only and Comparing Neoadjuvant to Adjuvant Total Androgen Suppression (TAS) Terminated III
9501 Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head and Neck Terminated III
9506 A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed Either By Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder Cancer Terminated I/II
9512 A Randomized Study of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord Terminated III
9514 A Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall Terminated II
9517 A Phase I/II Trial to Evaluate Brachytherapy as the Sole Method of Radiation Therapy for Stage I and II Breast Carcinoma Terminated I/II
9609 Phase II Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined with Twice Daily Thoracic Radiotherapy for Patients with Limited Stage Small Cell Lung Cancer Terminated II
9610 Phase I/II Study of Concomitant Re-Irradiation, Hydroxyurea and 5-Fluorouracil in Patients with Recurrent Squamous Cell Cancer of the Head and Neck Terminated I/II
9612 Phase II Study of Chemoradiation in Patients with Locally Extensive Epidermoid Carcinoma of the Vulva Terminated II
9613 A Phase II Study of Extended Field Radiation Following Therapeutic Para-Aortic Node Dissection for Patients with Carcinoma of the Uterine Cervix with Para-Aortic Nodal Metastases Terminated II
9614 ECOG E4393: Clinical Efficacy of Molecular Analysis of Surgical Margins and Regional Lymph Nodes in Management of Head and Neck Squamous Cell Carcinoma Terminated CS
9615 Phase II Multi-Institutional Trial of Targeted Supradose Cisplatin Chemoradiation for Stage IV Squamous Cell Carcinoma of the Head and Neck Terminated II
9701 Phase III Randomized Trial of Radiation Therapy Alone versus Concurrent Chemotherapy plus Radiation Therapy for Poor-Risk Stage III Non-Small-Cell Lung Carcinoma Terminated III
9702 CALGB 9343: Evaluation of Lumpectomy, Tamoxifen, and Irradiation of the Breast Compared with Lumpectomy plus Tamoxifen in Women 70 Years of Age or Older Who Have Carcinoma of the Breast That Is Less Than or Equal To 2 cm and Clinically Negative Axillary Nodes: A Phase III Study Terminated III
9703 A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck Terminated II
9704 A Phase III Study of Pre and Post Chemoradiation 5-FU Vs. Pre and Post Chemoradiation Gemcitabine for Postoperative Adjuvant Treatment of Resected Pancreatic Adenocarcinoma Terminated III
9705 Phase II Study of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II and Stage IIIA Non-small Cell Lung Cancer Terminated II
9706 A Phase I/II Trial in Operable Patients with Muscle-Invading Bladder Cancer of Transurethral Surgery and Cisplatinum/ Bid Irradiation Followed either by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy Terminated I/II
9707 Phase I/II Study of Concomitant Parametrial Boost Radiation Therapy for Locally Advanced Cervical Cancer Terminated I/II
9708 A Phase II Study of Adjuvant Postoperative Irradiation Combined with Cisplatin/Taxol chemotherapy Following TAH/BSO for Patients with High-Risk Endometrial Cancer Terminated II
9709 A Phase III Study to Test the Efficacy of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated With Curative Radiation Therapy in Head and Neck Cancer Patients Terminated III
9710 A Phase II Study of Conventional Radiation Therapy Followed with Recombinant Interferon Beta for Supratentorial Glioblastoma Terminated II
9712 A Phase I Dose Escalation Study of Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer Terminated I
9713 Phase III Randomized Study Comparing Best Supportive Care to Biafine® as a Prophylactic Agent for Radiation-Induced Skin Toxicity for Women Undergoing Breast Irradiation Terminated III
9714 Randomized Trial of Palliative Radiation Therapy For Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life For Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life Terminated I
9801 A Phase III Study of Amifostine Mucosal Protection For Patients With Favorable Prognosis Inoperable Stage II-IIIA/B Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Induction and Concurrent Hyperfractionated Radiotherapy With Paclitaxel and Carbopl Terminated III
9803 Phase I/II Radiation Dose Escalation Study Applying Conformal Radiation Therapy in Supratentorial Glioblastoma Multiforme Terminated I/II
9805 Phase II Trial of Transrectal Ultrasound Guided Permanent Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate Terminated II
9806 A Phase II Study of Conventional Radiation Therapy Plus Thalidomide for Supratentorial Glioblastoma Terminated II
9809 Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy Terminated III
9811 A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Flourouracil, Cisplatin and Radiotherapy in Carcinoma of the Anal Canal Terminated III
9812 A Phase II Trial of External Irradiation (50.4 GY) and Weekly Paclitaxel (Taxol) for Non-Metastatic, Unresectable Pancreatic Cancer Terminated II
9901 A Phase III Study to Test the Efficacy and Safety of GM-CSF to Reduce the Severity and Duration of Mucosal Injury and Pain (Mucositis) Associated With Curative Radiation Therapy in Head and Neck Cancer Patients Terminated III
9902 A Phase III Protocol of Total Androgen Suppression (TAS) and Radiation Therapy (RT) vs TAS and RT Followed by Chemotherapy with Paclitaxel, Estramustine, and Etoposide (TEE) for Localized, High-Risk, Prostate Cancer Terminated III
9903 A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated with Radiotherapy for Carcinoma of the Head and Neck Terminated III
9904 A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy For Potentially Resectable Adenocarcinoma of the Stomach Terminated II
9905 A Phase III Study of Adjuvant Postoperative Irradiation With or Without Cisplatin/Paclitaxel Chemotherapy Following TAH/BSO for Patients With Endometrial Cancer Terminated III
9906 A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and BID Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy Terminated I/II
9909 A Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients with Completely Resected Stage I and Stage IIIA Non-Small Cell Lung Cancer Terminated II
9911 Phase II Study of Paclitaxel and Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer of the Head and Neck Terminated II
9913 A Phase III Comparison of Biafiner to Declared Institutional Preference for Radiation Induced Skin Toxicity In Patients Undergoing Radiation Therapy for Advanced Squamous Cell Carcinomas of the Head and Neck Terminated III
9914 A Phase II Trial of Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas Terminated II